

Presented by
Aging Initiative at Harvard
Connecting Boston's aging research community
Hosted By

Featured in
Boston
Gene Editing for Cardiovascular Disease: Sek Kathiseran, Verve Tx
Registration
Approval Required
Your registration is subject to approval by the host.
About Event
Sek Kathiseran is the Founder & CEO of Verve Therapeutics, a company developing one-time genetic medicine treatments for cardiovascular disease.
Presented by
Aging Initiative at Harvard
Connecting Boston's aging research community
Hosted By